US panel endorses non-inferiority studies for complicated skin infections
This article was originally published in Scrip
Executive Summary
A US FDAadvisory panel has overwhelmingly endorsed the use of non-inferiority studies for antibiotics to treat complicated skin and skin structure infections (cSSSI) but not for uncomplicated infections (uSSSI).